Although mitophagy factors described above are shown to be dysregulated in cancer patients, it should be noted that whether they act as a tumor suppressor or promoter depends on cellular subtypes and cancer stages (e.g., BNIP3 is also suggested to support melanoma migration (Maes et al, 2014)). Here, BNIP3 is linked to cancer.